financeMarketWatch
Novo drops ‘Nordisk’ in corporate refresh to take on Lilly in the weight-loss wars
September 14, 2026
The Danish drug giant behind Ozempic is competing with Eli Lilly in the market for weight-loss drugs.
GN Media aggregates headlines — read the full story on MarketWatch.
Read full story on MarketWatch
